Feb 24, 2021
Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI
May 21, 2020
Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19
Apr 27, 2020
Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
Apr 14, 2020
Insilico enters into a research collaboration with Boehringer Ingelheim to apply novel generative artificial intelligence system for discovery of potential therapeutic targets
Mar 16, 2020
Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy
Oct 16, 2019
Insilico Medicine and ChemDiv form a strategic drug discovery service alliance
Oct 09, 2019
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million
Oct 17, 2018
MarketsandMarkets to Host Artificial Intelligence in Healthcare Conference in Boston
Aug 14, 2018
The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
Jun 19, 2018
Insilico Medicine Earns Accolades from Frost & Sullivan for Its Pioneering R&D in AI for Aging Research and Drug Discovery
Jun 11, 2018
WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence
Dec 19, 2017
GEROPROTECT(TM) Longevity A.I.(TM) from Life Extension® provides anti-aging extracts that targets the anti-aging pathways
Nov 28, 2017
Study using artificial intelligence to identify compounds that mimic the longevity effects of calorie restriction published in November 2017 issue of Aging Journal